INS and Insulin resistance: Interestingly, responders exhibited insulin resistance and dyslipidemic phenotypes with higher homeostatic model assessment for insulin resistance and β-cell function (HOMA-IR and HOMA- β, respectively), TC, LDL-c, and lower quantitative insulin sensitivity check index (QUICKI) at baseline compared to non-responders (30).